LIVE SESSION BRIEF Biotechnology $150M Cap Quant: HOLD

Compugen Ltd (CGEN) — Live Session & Technical Brief

Updated Nov 17, 2026 4:23 PM ET · Prev Close $2.04

Pro Workspace
Last Session Price
$2.02 -0.98%
-$0.02 vs $2.04 prior close
Intraday Range
$1.98 – $2.05
Open $1.99
Relative Volume
0.82x Avg
197,679 sh
52-Week Range
$1.43 – $3.23
Benchmark Alpha
+0.03% vs SPY
-0.25% vs QQQ
20-Session Trend -4.7%

Session Regime & Catalyst Assessment

64% Signal Conviction
TECHNICAL 64% Driver Weight

Controlled Session Consolidation (-0.98%) in Biotechnology

Compugen Ltd (CGEN) is trading within a tight intraday band at $2.02 (-0.98%, 0.82x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, CGEN is trading in line with the S&P 500 (+0.03% alpha). 14-day RSI stands at 46.9, keeping momentum in a bearish regime.

NEWS 70% Weight
Compugen Ltd Cgen Q3 2026 Earnings Call Highlights Revenue Doubles as Gilead and AstraZeneca ...

Compugen Ltd CGEN posted 3.8 million in Q3 2026 revenue, completed MAIA-ovarian enrollment with data due by Q1 2027, and holds 117.5 million in cash to fund operations into 2029.

TECHNICAL 68% Weight
Moving Average Structure: Mixed Alignment

Price ($2.02) trades relative to 20-day SMA ($2.02) and 50-day SMA ($2.18).

Volume Confirmation
LOW VOLUME (0.82x) Consolidation
Sub-average participation — monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 64%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

CGEN trading in line with the S&P 500 (+0.03% alpha)
CGEN Session
-0.98%
$2.02
S&P 500 (SPY)
-1.01%
$732.44
Nasdaq 100 (QQQ)
-0.73%
$656.95
Healthcare (XLV)
-1.41%
$185.24
Alpha vs SPY: +0.03% Alpha vs QQQ: -0.25% Alpha vs XLV: +0.43%

Recent CGEN Catalyst Headlines

Verified Wire
What Compugen CGEN Said on Its Q3 Earnings Call

Compugen Nasdaq Cgen has completed enrollment in a randomized trial of its ovarian cancer treatment candidate COM701 and expects to report results by the end of the first quarter of 2027, executives said on the company s

Yahoo Finance · Nov 09, 2026

1–3 Day Expected Range & Key Level

48% Follow-Through
Lower Bound
$1.96
Short-term support band
Upper Bound
$2.08
Short-term resistance band
Key Inflection Level
$2.02 (20-day SMA support)

Monitor volume expansion above 1.5x RVOL around $2.02 (20-day SMA support) for directional breakout confirmation.

Technical Regime (CGEN)

MIXED MA TREND
RSI (14)
46.9
Bearish
20-Day SMA
$2.02
Above 20d
50-Day SMA
$2.18
Below 50d
MACD Signal
Bullish
MACD -0.02
ADX (14)
13.8
Weak trend
10d Momentum
+0.03
Positive 10-day momentum

Retail & Crowd Sentiment

Quiet
24h Messages
0
7d avg 0.0
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

StockTwits messages indicate a strong bullish sentiment towards $CGEN, with buyers taking positions or adding significantly. No recent news articles were found.

About Compugen Ltd

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. …

Sector
Healthcare
Market Cap
$150M
Employees
74

Get Instant CGEN Catalyst Alerts

Receive an email alert when CGEN triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

CGEN Session & Catalyst FAQ

Why is CGEN stock trading near flat today?

Compugen Ltd (CGEN) is trading within a tight intraday band at $2.02 (-0.98%, 0.82x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, CGEN is trading in line with the S&P 500 (+0.03% alpha). 14-day RSI stands at 46.9, keeping momentum in a bearish regime.

Is CGEN stock a buy or sell right now?

Today's session carries a 64% catalyst conviction score on 0.82x relative volume (low participation). Our multi-factor model currently rates CGEN as HOLD. Review full valuation, quality, and timing signals on the CGEN Buy or Sell Decision Brief →

What is CGEN's intrinsic value and expected trading range?

At $2.02, CGEN's modeled 1-to-3 session range is $1.96 – $2.08, with a key inflection level at $2.02 (20-day SMA support). Compare current price against multi-year cash flow projections in the CGEN Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for CGEN?

RSI at 46.9 reflects soft below-midline momentum. CGEN trades at $2.02 relative to its 20-day SMA ($2.02) and 50-day SMA ($2.18), reflecting a mixed moving-average structure.

Tradestie Flagship Research & Market Hubs